• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

Introduction to 4-(6-Methyl-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde (CAS No. 128376-66-9)

4-(6-Methyl-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde is a sophisticated organic compound characterized by its unique structural and functional properties. This compound, identified by the CAS number 128376-66-9, has garnered significant attention in the field of pharmaceutical chemistry and materials science due to its versatile applications. The presence of a dioxazaborocan moiety in its molecular structure imparts distinctive reactivity and stability, making it a valuable intermediate in synthetic chemistry.

The dioxazaborocan group is a boron-containing heterocyclic ring that plays a crucial role in facilitating various chemical transformations. Specifically, the boronic acid functionality within this moiety enables participation in cross-coupling reactions such as Suzuki-Miyaura and Sonogashira couplings, which are pivotal in constructing complex molecular architectures. These reactions are widely employed in the synthesis of pharmaceuticals, agrochemicals, and advanced materials.

Recent advancements in medicinal chemistry have highlighted the potential of 4-(6-Methyl-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde as a key building block for developing novel therapeutic agents. Its benzaldehyde moiety serves as an aromatic aldehyde group, which is a common pharmacophore in drug design. This group is known for its ability to interact with biological targets through hydrogen bonding and other non-covalent interactions, enhancing the binding affinity of drug candidates.

Moreover, the methyl substituent at the 6-position of the dioxazaborocan ring contributes to the compound's overall steric and electronic properties. This substitution can influence the reactivity and selectivity of the boronic acid moiety, allowing for precise control during synthetic procedures. Such tunability is highly desirable in drug development pipelines where optimizing molecular interactions is critical for efficacy and safety.

In the realm of materials science, 4-(6-Methyl-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde has been explored for its potential applications in organic electronics. The boron-containing heterocycle can be incorporated into polymers and small-molecule semiconductors to enhance charge transport properties. These materials are integral to next-generation technologies such as organic light-emitting diodes (OLEDs), photovoltaic cells, and field-effect transistors (FETs).

Recent studies have demonstrated the utility of this compound in designing novel boronic acid-based polymers with improved thermal stability and mechanical strength. Such polymers are particularly relevant for applications requiring high-performance materials under extreme conditions. The dioxazaborocan unit's ability to form stable complexes with metal ions also opens avenues for developing metal-organic frameworks (MOFs) with tailored functionalities.

The synthesis of 4-(6-Methyl-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde typically involves multi-step organic transformations starting from readily available precursors. The introduction of the dioxazaborocan ring requires careful control of reaction conditions to ensure high yield and purity. Advances in catalytic systems have enabled more efficient synthetic routes, reducing waste and improving scalability.

From a computational chemistry perspective, theoretical studies have been instrumental in understanding the reactivity patterns of this compound. Molecular modeling techniques have revealed insights into how the benzaldehyde group interacts with biological targets at an atomic level. These insights are invaluable for rational drug design and optimizing lead compounds during early-stage development.

The pharmaceutical industry has shown particular interest in derivatives of 4-(6-Methyl-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde due to their potential as kinase inhibitors and antiviral agents. The boron atom's Lewis acidity makes it an excellent scaffold for coordinating with metal ions involved in enzymatic pathways. This property has been leveraged to develop small-molecule inhibitors that disrupt disease-causing mechanisms.

In conclusion,4-(6-Methyl-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde (CAS No. 128376-66-9) represents a fascinating compound with broad applications across multiple scientific disciplines. Its unique structural features make it a versatile tool for synthetic chemists and material scientists alike. As research continues to uncover new functionalities and applications,this compound is poised to play an increasingly important role in advancing chemical innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)